These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15834642)

  • 21. Relationship between age and subtypes of psychotic symptoms in Parkinson's disease.
    Kiziltan G; Ozekmekçi S; Ertan S; Ertan T; Erginöz E
    J Neurol; 2007 Apr; 254(4):448-52. PubMed ID: 17401525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual hallucinations in Parkinson's disease: a review and phenomenological survey.
    Barnes J; David AS
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):727-33. PubMed ID: 11385004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of hallucinations in Parkinson's disease using a novel scale.
    Wada-Isoe K; Ohta K; Imamura K; Kitayama M; Nomura T; Yasui K; Nakaso K; Nakashima K
    Acta Neurol Scand; 2008 Jan; 117(1):35-40. PubMed ID: 18095953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Psychoses in patients with Parkinson's disease; their frequency, phenomenology, and clinical correlates].
    Kashihara K; Ohno M; Katsu Y
    Rinsho Shinkeigaku; 2005 Jan; 45(1):1-5. PubMed ID: 15714992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset.
    Diederich NJ; Moore CG; Leurgans SE; Chmura TA; Goetz CG
    Arch Neurol; 2003 Apr; 60(4):529-33. PubMed ID: 12707066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between family history of dementia and hallucinations in Parkinson disease.
    Paleacu D; Schechtman E; Inzelberg R
    Neurology; 2005 May; 64(10):1712-5. PubMed ID: 15911796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A registry-based, case-control investigation of Parkinson's disease with and without cognitive impairment.
    Papapetropoulos S; Ellul J; Polychronopoulos P; Chroni E
    Eur J Neurol; 2004 May; 11(5):347-51. PubMed ID: 15142230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depression.
    Morgante L; Colosimo C; Antonini A; Marconi R; Meco G; Pederzoli M; Pontieri FE; Cicarelli G; Abbruzzese G; Zappulla S; Ramat S; Manfredi M; Bottacchi E; Abrignani M; Berardelli A; Cozzolino A; Paradiso C; De Gaspari D; Morgante F; Barone P;
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):76-82. PubMed ID: 21836035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hallucinations in Parkinson's disease].
    Moser A; Hagenah J; Kömpf D
    Nervenarzt; 2003 Apr; 74(4):376-85, quiz 385-6. PubMed ID: 12707709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Features associated with the development of hallucinations in Parkinson's disease.
    Benbir G; Ozekmekçi S; Cinar M; Beskardes F; Apaydin H; Erginöz E
    Acta Neurol Scand; 2006 Oct; 114(4):239-43. PubMed ID: 16942542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Categorising Visual Hallucinations in Early Parkinson's Disease.
    Clegg BJ; Duncan GW; Khoo TK; Barker RA; Burn DJ; Yarnall AJ; Lawson RA
    J Parkinsons Dis; 2018; 8(3):447-453. PubMed ID: 30040741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early dopaminergic drug-induced hallucinations in parkinsonian patients.
    Goetz CG; Vogel C; Tanner CM; Stebbins GT
    Neurology; 1998 Sep; 51(3):811-4. PubMed ID: 9748031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study.
    Aarsland D; Larsen JP; Cummins JL; Laake K
    Arch Neurol; 1999 May; 56(5):595-601. PubMed ID: 10328255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease.
    Lee JY; Kim JM; Ahn J; Kim HJ; Jeon BS; Kim TW
    Mov Disord; 2014 Jan; 29(1):61-7. PubMed ID: 23775932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive correlates of visual hallucinations in non-demented Parkinson's disease patients.
    Hepp DH; da Hora CC; Koene T; Uitdehaag BM; van den Heuvel OA; Klein M; van de Berg WD; Berendse HW; Foncke EM
    Parkinsonism Relat Disord; 2013 Sep; 19(9):795-9. PubMed ID: 23706540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study.
    Williams DR; Lees AJ
    Lancet Neurol; 2005 Oct; 4(10):605-10. PubMed ID: 16168928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visual hallucinations in Parkinson's disease are associated with thinning of the inner retina.
    Visser F; Apostolov VI; Vlaar AMM; Twisk JWR; Weinstein HC; Berendse HW
    Sci Rep; 2020 Dec; 10(1):21110. PubMed ID: 33273513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hallucinations, delusions, and nocturnal events in 152 Parkinson's patients: a regional survey].
    Bailbé M; Karolewicz S; Neau JP; Dumas P; Gil R;
    Rev Neurol (Paris); 2002 Feb; 158(2):203-10. PubMed ID: 11965176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Levodopa-induced psychosis in patients with idiopathic Parkinson disease].
    García-Escrig M; Bermejo Pareja F; Fernández Ponsatí JT
    Med Clin (Barc); 1999 Feb; 112(7):245-50. PubMed ID: 10220750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.